Appl Environ Microbiol 2004, 70:1442–1447.PubMedCentralPubMedCrossRef 33. Thakur S, Gebreyes WA: Prevalence and antimicrobial resistance of Campylobacter in antimicrobial-free and conventional pig production systems. J Food Prot 2005, 68:2402–2410.PubMed RG7112 solubility dmso 34. Norma PV, Friendship R, Dewey C: Prevalence of resistance to 11 antimicrobials among Campylobacter coli isolated from pigs on 80 grower-finisher farms

in Canada. Can J Vet Res 2007, 71:189–194. 35. Oosterom J, Dekker R, De Wilde GJA, van Kempen-de TF, Engels GB: Prevalence of Campylobacter jejuni and Salmonella during pig slaughtering. Vet Q 1985, 7:31–32.PubMedCrossRef 36. Nesbakken T, Eckner K, ROtterud OJ: The effect of blast chilling on occurance of human pathogenic Yersinia enterocolitica compared to Campylobacter

spp. and numbers of hygienic indicator on pig carcass. Int J Food Microbiol 2008,123(1–2):130–133.PubMedCrossRef 37. ICMSF: Micro-Organisms in Foods 6. Microbial Ecology selleck chemicals of Food Commodities. International Commission on Microbiological Specifications for Foods (ICMSF). London: Blackie Academic and Professional; 1998. Competing interests None of the authors have any competing interests. Authors’ contributions LG participated in study design, bacterial culture, data analysis and drafting manuscript, DKS participated in data analysis and bacterial culture identification, HBB participated in bacterial culture and identification, antibiogram and drafting manuscript, RKB conducted bacterial culture, antibiogram and assisted in

drafting manuscript, SD participated in data analysis and interpretation, survey of butchers and manuscript preparation and BS participated in bacterial culture, survey of butchers and drafting manuscript. All the authors read and approved the final manuscript.”
“Background Bacterial drug resistance is a growing global health challenge. Resistant infections are difficult to treat, tend to spread relatively rapidly and increase healthcare costs significantly Methane monooxygenase [1]. Empiric antibiotic therapy is commonly started before the results of antimicrobial susceptibility testing (AST) are available. This is mainly because the available AST methods are slow, typically requiring 24–72 hours, being primarily based on bacterial growth. Inappropriate empiric antibiotic regimens can be associated with treatment failures/prolonged illness [2, 3], and may also serve to promote resistant bacterial strains [4–7]. Pre-prescription AST, such as rapid point-of-care diagnostics, that can help identify the most effective antibiotic for bacterial infections would be advantageous, especially in the context of escalating resistance [8–10]. Bacterial antibiotic resistance can be due to a variety of mechanisms, including enzymatic inactivation of antibiotics, altered target sites, decreased uptake and/or increased efflux of the antimicrobial agents [11]. Multiple resistance factors can be present simultaneously [12, 13].